Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Saphnelo
Pharma
AZ touts phase 3 lupus win for subcutaneous Saphnelo
AstraZeneca is looking to bring a subcutaneous version of its 2021-approved Saphnelo to more patients after nabbing a European nod last month.
Zoey Becker
Jan 6, 2026 11:44am
Roche's cancer med Gazyva scores FDA nod in lupus nephritis
Oct 20, 2025 10:15am
AZ's Fasenra flunks COPD trial as Saphnelo makes grade in lupus
Sep 17, 2025 11:47am
Off-label drugs fall out of favor in lupus
Jun 16, 2023 10:16am
AZ rolls out first DTC campaign for lupus drug Saphnelo
May 11, 2022 4:47pm
AstraZeneca preps new lupus launch with patient-designed support
Aug 2, 2021 4:00pm
